ALK/ROS1/MET Mutations on Plasma ctDNA in Patients With NSCLC

Clinical trial NCT02946216 · UNKNOWN

Trial details

NCT number: NCT02946216
Sponsor: First People's Hospital of Hangzhou
Status: UNKNOWN
Study type: OBSERVATIONAL

Non-small Cell Lung Cancer Stage III Non-Small-Cell Lung Cancer Metastatic Adenocarcinoma of Lung EGFR Wildtype

Start date: 2016-11-01
Primary completion: 2017-11-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.